RT Journal Article
T1 Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study.
A1 Ruiz de Adana, Maria S
A1 Alhambra-Exposito, Maria Rosa
A1 Muñoz-Garach, Araceli
A1 Gonzalez-Molero, Inmaculada
A1 Colomo, Natalia
A1 Torres-Barea, Isabel
A1 Aguilar-Diosdado, Manuel
A1 Carral, Florentino
A1 Serrano, Manuel
A1 Martinez-Brocca, Maria A
A1 Duran, Ana
A1 Palomares, Rafael
K1 Área de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
K1 Blood glucose
K1 Diabetes Mellitus, type 1
K1 Dose-response relationship, drug
K1 Follow-up studies
K1 Glycated hemoglobin
AB To assess the impact of a telemedicine visit using the platform Diabetic compared with a face-to-face visit on clinical outcomes, patients' health-related quality of life (HRQoL), and physicians' satisfaction in patients with type 1 diabetes. PLATEDIAN (Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients) (NCT03332472) was a multicenter, randomized, 6-month follow-up, open-label, parallel-group controlled study performed in patients with type 1 diabetes with suboptimal metabolic control (HbA1c  At month 6, the mean change in HbA1c levels was -0.04 ± 0.5% (-0.5 ± 5.8 mmol/mol) in the CC and 0.01 ± 0.6% (0.1 ± 6.0 mmol/mol) in the IC (P = 0.4941). The number of patients who achieved HbA1c  The use of telemedicine in patients with type 1 diabetes with HbA1cc <8% (<64 mmol/mol) provides similar efficacy and safety outcomes as face-to-face visits.
PB American Diabetes Association
YR 2019
FD 2019-12-16
LK http://hdl.handle.net/10668/14823
UL http://hdl.handle.net/10668/14823
LA en
NO Ruiz de Adana MS, Alhambra-Expósito MR, Muñoz-Garach A, Gonzalez-Molero I, Colomo N, Torres-Barea I, et al. Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study. Diabetes Care. 2020 Feb;43(2):337-342
DS RISalud
RD Apr 8, 2025